Hinge Health, Inc. (HNGE) Tops Q3 EPS by 19c

Hinge Health, Inc. (NYSE: HNGE) reported Q3 EPS of ($0.02), $0.19 better than the analyst estimate of ($0.21). Revenue for the quarter came in at $154.2 million versus the consensus estimate of $0 .

GUIDANCE:

Hinge Health, Inc. sees Q4 2025 revenue of $155-157 million, versus the consensus of $145.4 million.

Hinge Health, Inc. sees FY2025 revenue of $572-574 million, versus the consensus of $550.5 million.

For earnings history and earnings-related data on Hinge Health, Inc. (HNGE) click here.

You May Also Be Interested In

• Nscale targets up to $3B in US IPO as soon as September - Bloomberg
• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• Greenland approves rare earths license transfer to Greenland Mines